Human epidermal growth factor receptor 2 expression in early breast cancer patients: a Swiss cost–effectiveness analysis of different predictive assay strategies

Author： Blank Patricia  

Publisher： Springer Publishing Company

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.124, Iss.2, 2010-11, pp. : 497-507

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pertuzumab for the treatment of patients with human epidermal growth factor receptor 2positive breast cancer in Japan

By        

Molecular and Clinical Oncology, Vol. 3, Iss. 6, 2015-01 ,pp. : 1268-1274

Science Publishers

Access to resources Recommend Favorite

Significance of human epidermal growth factor receptor 2 expression in colorectal cancer

By  

Experimental and Therapeutic Medicine, Vol. 9, Iss. 1, 2015-01 ,pp. : 17-24

Spandidos Publications

Access to resources Recommend Favorite

Gene expression profiling of histologically normal breast tissue in females with human epidermal growth factor receptor 2positive breast cancer

By  

Molecular Medicine Reports, Vol. 11, Iss. 2, 2015-01 ,pp. : 1421-1427

Spandidos Publications

Access to resources Recommend Favorite

Human epidermal growth factor receptor 2 protein expression between primary breast cancer and paired asynchronous local-regional recurrences

By                

Experimental and Therapeutic Medicine, Vol. 2, Iss. 6, 2011-01 ,pp. : 1187-1191

Spandidos Publications

Access to resources Recommend Favorite

Serum folliclestimulating hormone level is associated with human epidermal growth factor receptor type 2 and Ki67 expression in postmenopausal females with breast cancer

By            

Oncology Letters, Vol. 6, Iss. 4, 2013-01 ,pp. : 1128-1132

Spandidos Publications

Access to resources Recommend Favorite